Sequist installed as inaugural Landry Family Associate Professor of Medical Oncology

Giving

More... Share to Twitter Share to Facebook
Sequist installed as inaugural Landry Family Associate Professor of Medical Oncology

Lecia Sequist, MD ’99, MPH ’05, director of the Center for Innovation in Early Cancer Detection and a medical oncologist in the Center for Thoracic Cancers at the Massachusetts General Hospital (MGH) Cancer Center, has been named to the Landry Family Professorship in Medical Oncology. This professorship was made possible by the generosity of the Landry family, whose patriarch, Kevin Landry, AB ’66, passed away from lung cancer in 2013.

Sequist (fourth from left) celebrates her installation with (left to right) Kimberly GwinnLandry; Nancy Tarbell, MD, dean for academic and clinical affairs and C.C. Wang Professor of Radiation Oncology at HMS; Barrie Landry; Jennifer Landry Le; and Daniel Haber, MD, PhD, director of the MGH Cancer Center and the Kurt Isselbacher Professor of Oncology at HMS.r Center and the Kurt Isselbacher Professor of Oncology at HMS.

Sequist joined the MGH and HMS faculty in 2005. Over the past 10 years, she has focused her research on precision therapy for lung cancer, spearheading the development of several new therapeutics and pioneering research using both tumor biopsies and liquid biopsies to understand the development of drug resistance and the clonal evolution of cancer.

Our

Mission

To create and nurture a diverse community of the best people committed to leadership in alleviating human suffering caused by disease.